The European Medicines Agency (EMA) is 20 years old this year - and it confronts many of the problems familiar to anyone at that age.
The European Medicines Agency (EMA) is 20 years old this year - and it confronts many of the problems familiar to anyone at that age. After the vigorous growth and boundless optimism of its early adolescence, the agency now must make up its mind about what it wants to be.
This is not just a matter of defining its personality. It also means taking on greater responsibility obtaining the resources it will need, and asserting its mission successfully in the face of the often harsh realities of the outside world.
The agency’s own sharpened awareness of the complex conditions beyond Canary Wharf, London, offices is its programme for 2014, which identifies half a dozen new priorities. As EMA’s executive director, Guido Rasi, publicly observed at the end of last year, “The environment in which we are operating is ever-changing, continuously presenting us with new challenges.”
For Reflector’s incisive look at the EMA’s growing pains as it faces the key policy challenges of 2014, see February’s issue of Pharmaceutical Executive, or click here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.